• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

XTL Biopharmaceuticals Ltd

+ Add to Watchlist

H2K1:GR

2.288 EUR 0.174 7.07%

As of 09:34:49 ET on 07/28/2014.

Snapshot for XTL Biopharmaceuticals Ltd (H2K1)

Open: 2.290 Day's Range: 2.288 - 2.290 Volume: 0
Previous Close: 2.462 52wk Range: 1.500 - 5.291 1-Yr Rtn: -50.86%

Stock Chart for H2K1

No chart data available.
  • H2K1:GR 2.288
  • 1D
  • 1M
  • 1Y
2.462
Interactive H2K1 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for H2K1

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 26.64
Shares Outstanding (M) 11.64
30 Day Average Volume 7
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/28/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for H2K1

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for H2K1

XTL Biopharmaceuticals, Ltd. is a biopharmaceutical company. The Company offers acquisition and development of pharmaceutical products for the treatment of unmet medical needs, particularly the treatment of multiple myeloma and hepatitis X.

David GrossmanChief Executive OfficerDavid KestenbaumChief Financial Officer
Moshe MittelmanDirector:Medical
More Company Profile & Key Executives for H2K1

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil